FCB
GILD icon

First Citizens Bancorporation’s Gilead Sciences GILD Stock Holding History

First Citizens Bancorporation’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$842K Buy
8,932
+695
+8% +$71.9K 0.57% 78
2014
Q3 		$877K Buy
8,237
+3,307
+67% +$324K 0.63% 72
2014
Q2 		$409K Buy
+4,930
New +$384K 0.31% 83

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Citizens Bancorporation's GILD Position: Q4 2014 in Review

First Citizens Bancorporation increased its Gilead Sciences (GILD) stake by 8.4% in Q4 2014, buying an estimated $71.9K and bringing the position to 8,932 shares worth $842K. The position accounts for 0.57% of the portfolio, ranked #78.

First Citizens Bancorporation first reported a position in GILD in Q2 2014 and has held it in 3 quarters since. The position peaked at $877K in Q3 2014. 1,438 funds tracked by Wall St. Rank hold GILD as of Q4 2014.

  • First Citizens Bancorporation held 8,932 shares of Gilead Sciences worth $842K as of Q4 2014.
  • First Citizens Bancorporation bought 695 Gilead Sciences shares in Q4 2014, an estimated $71.9K.
  • Gilead Sciences made up 0.57% of First Citizens Bancorporation's portfolio in Q4 2014, its #78 holding.
  • First Citizens Bancorporation first reported a position in Gilead Sciences in Q2 2014 and has held it in 3 quarters since.
  • First Citizens Bancorporation's Gilead Sciences position peaked at $877K in Q3 2014.
  • 1,438 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2014.

Based on First Citizens Bancorporation's 13F filing for Q4 2014, filed 21 Jan 2015.